Pharmacogenomics (PGX) Testing
Pharmacogenomics (PGX) Testing
Regular price
Sale price
Regular price
Sold out
Unit price
- +

Important Note: After purchasing, you will receive two separate emails:

  1. Doc-U-Sign which needs to be filled out and submitted
  2. Instructions on next steps  

With pharmacogenomic testing, Helix Lab Solutions is able to establish the correct drug/dose for each individual patient. This testing aids in potentially minimizing adverse drug events, as well as improving patient drug compliance. Most importantly, Helix Lab Solutions helps providers to lessen patients’ daily medications while optimizing treatment plans.

82% of Americans are prescribed and utilize 1 medication daily. 29% of Americans utilize 5 or more prescribed medications. With Pharmacogenomic testing, we help the patient to minimize the amount of prescription medications they take daily.

Research shows that patients who undergo Pharmacogenomics testing have a maximal outcome regarding treatment. As well as minimizing adverse effects and costs for prescriptions.

Cardiovascular Health:

Our cardiovascular health profile helps to determine the therapeutic value of commonly used drugs for certain cardiovascular conditions. As well as determining the risk of thrombosis or prothrombin deficiency.

Genes included in the cardio health panel: ADRA2A, APOE, COMT, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, FACTOR II, FACTOR V, ITGB3, MTHFR, SLCO1B1, UGT2B15, VKORC1

Pain Management:

Our pain management profile provides clinicians with information to improve drug selection and dosing for the individual patients, and the most optimal personalized approach to treatment.

Genes included in the pain management panel: COMT, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, DRD2, HTR2A, HTR2C, MTHFR, OPRM1, SLCO1B1, TPMT, UGT2B15, VKORC1

Mental Health:

Our mental health profile helps to achieve therapeutic benefits quickly and efficiently. As well as including a prediction for  potential variability, meanwhile working to minimize potential adverse drug reactions.

Genes included in the mental health panel: ADRA2A, COMT, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, DRD2, GRIK4, HTR2A, HTR2C, MTHFR, SLCO1B1, TPMT, UGT2B15, VKORC1